BeatO, a diabetes care startup, raised $33 million led by Lightrock India to enhance its operations and extend its access to affordable diabetes management solutions across India.

Information on the Target

BeatO, a diabetes care startup, has successfully raised $33 million in a funding round led by Lightrock India. This investment also saw participation from HealthQuad, Flipkart Ventures, and existing investors such as Blume Ventures and Leo Capital. The company aims to utilize the newly acquired capital to enhance its operations, recruit top-tier leadership, and invest in both hardware and software products. Additionally, BeatO seeks to extend its reach to a broader customer base across India.

Focusing on affordability and accessibility, BeatO is dedicated to providing diabetes care, particularly for individuals who lack access to specialized treatment. The startup offers an app that allows users to monitor glucose levels and other health metrics, alongside devices that connect to smartphones to collect data. Furthermore, it provides telemedicine services, enabling users to consult doctors remotely.

Industry Overview in India

India is on track to become the global epicenter of diabetes, anticipated to surpass China with more than 200 million individuals at risk due to lifestyle choices. This alarming trend highlights the increasing prevalence of diabetes within t